Diffuse proliferative glomerulonephritis associated with dermatomyositis with nephrotic syndrome

Rheumatol Int. 2010 Apr;30(6):821-5. doi: 10.1007/s00296-009-1003-7. Epub 2009 Jun 17.

Abstract

We described a 44-year-old man developing dermatomyositis (DM) and nephrotic syndrome (NS). Renal biopsy revealed diffuse proliferative glomerulonephritis (DPGN) with depositions of immunoglobulin and complements. A combination therapy of steroid and cyclophosphamide (CTX) was found very effective for the patient. Chronic glomerulonephritis is rare in DM. In our review of related literature, membranous glomerulonephritis (MN) is the main type of glomerular lesion, another type is mesangial proliferative glomerulonephritis (mesPGN). Here we reported a case of DM associated with DPGN developing NS, which was not found in existing literature. Although glomerulonephritis is uncommon in patients with DM, renal pathology is not as simplex as previously thought, and treatment with steroid or/and cytotoxic drugs is favorable for prognosis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Creatine Kinase, MB Form / administration & dosage
  • Cyclophosphamide / therapeutic use
  • Dermatomyositis / complications*
  • Dermatomyositis / pathology
  • Dermatomyositis / physiopathology
  • Glomerulonephritis / complications*
  • Glomerulonephritis / pathology
  • Glomerulonephritis / physiopathology
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kidney / drug effects
  • Kidney / pathology
  • Kidney / physiopathology
  • Kidney Tubules, Distal / drug effects
  • Kidney Tubules, Distal / immunology
  • Kidney Tubules, Distal / pathology
  • Male
  • Nephrotic Syndrome / complications*
  • Nephrotic Syndrome / pathology
  • Nephrotic Syndrome / physiopathology
  • Skin / drug effects
  • Skin / pathology
  • Skin / physiopathology
  • Steroids / therapeutic use
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Steroids
  • Cyclophosphamide
  • Creatine Kinase, MB Form